Previous close | 88.88 |
Open | 88.88 |
Bid | 75.70 |
Ask | 83.70 |
Strike | 50.00 |
Expiry date | 2024-12-20 |
Day's range | 88.88 - 88.88 |
Contract range | N/A |
Volume | |
Open interest | 1 |
OPKO Health's receipt of the additional funding from BARDA is expected to explore the MSTAR platform to prepare for outbreaks and respond rapidly to emerging viral threats.
Per the findings of the pivotal BLUE-C study, the Cologuard Plus test of Exact Sciences stands out for its high sensitivity at a specificity of 94%.
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today unveiled its MiSeq™ i100 Series of sequencing systems, delivering unparalleled benchtop speed and simplicity to advance next-generation sequencing (NGS) for labs.